Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification

Here we describe the first molecular test developed in the early stage of the pandemic to diagnose the first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Sardinian patients in February–March 2020, when diagnostic certified methodology had not yet been adopted by...

Descripción completa

Detalles Bibliográficos
Autores principales: Orrù, Germano, Scano, Alessandra, Fais, Sara, Loddo, Miriam, Carta, Mauro Giovanni, Steri, Giorgio Carlo, Santus, Simonetta, Cappai, Riccardo, Ferrando, Maria Laura, Coghe, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998653/
https://www.ncbi.nlm.nih.gov/pubmed/33802049
http://dx.doi.org/10.3390/pathogens10030325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998653/
https://www.ncbi.nlm.nih.gov/pubmed/33802049
http://dx.doi.org/10.3390/pathogens10030325

Ejemplares similares